Cervical Cancer Screening and Follow-Up Care

Recommended Follow-Up Protocol

For women with a history of abnormal Pap smear and cryotherapy, a repeat Pap test should be performed, with subsequent screening at 3-year intervals if results are normal and high-risk HPV testing is negative, as recommended by the Centers for Disease Control and Prevention (CDC) 1
The American College of Obstetricians and Gynecologists (ACOG) recommends that women aged ≥30 years, including this 67-year-old patient, undergo high-risk HPV DNA testing along with the Pap test as routine adjunctive testing 2
If both the Pap test is normal and high-risk HPV testing is negative, the screening interval can be increased to 3 years, according to the CDC 3

With negative high-risk HPV test: The CDC recommends resuming screening every 3 years 3
Without HPV testing: The CDC recommends annual screening for women with a history of abnormal results 5

For ASC-US, the CDC recommends three management options: prompt colposcopy, repeat Pap tests at 6 and 12 months, or high-risk HPV DNA testing, with immediate referral for colposcopy if high-risk HPV testing is positive 1, 2, 3, and 5
For ASC-H, LSIL, or HSIL, the CDC recommends immediate referral to a clinician who can perform colposcopic examination and colposcopically directed biopsy 1

The patient's age does not exempt her from continued screening, especially with her history of abnormal Pap and cryotherapy, as stated by the CDC 1
If colposcopy is required but unavailable in the current clinical setting, referral protocols should be established to ensure proper follow-up, according to the CDC 1
Patient education about the importance of continued surveillance is essential, as many women may not understand the purpose of ongoing Pap smears, as recommended by the CDC 5